Bacteriophage compositions for treating Staphylococcus infection
AssigneeArmata Pharmaceuticals, Inc.
InventorsStacey Lynn Kolar, Brian C. Varnum
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to bacteriophages and compositions capable of infecting and killing Staphylococcus, and use of the same for treating Staphylococcus, e.g. Staphylococcus aureus, bacterial infections.
Claims44
A method of treating a Staphylococcus aureus infection comprising administering a therapeutic composition to a subject in need of treatment, wherein the therapeutic composition comprises two or more bacteriophage, and wherein at least one bacteriophage comprises a polynucleotide sequence with at least 97% identity to SEQ ID NO:2.
A method of treating a Staphylococcus aureus infection comprising administering a therapeutic composition to a subject in need of treatment, wherein the therapeutic composition comprises one or more bacteriophage comprising a bacteriophage comprising a polynucleotide sequence with at least 97% identity to SEQ ID NO:2.
Dependencies are inferred from the claim text.